News | May 11, 2015

Twelve Late-Breaking Clinical Trials to be Presented at Heart Rhythm 2015

Key studies that will help advance electrophysiology at HRS

May 11, 2015 — The Heart Rhythm Society (HRS) has released the list of its 12 late-breaking electrophysiology (EP) clinical trials that will be presented at Heart Rhythm 2015, which takes place May 13-16, 2015 in Boston. 
 
Session I: Thursday, May 14, 1:30– 3 p.m. EDT in Ballroom West?
Impact of Remote Monitoring on Clinical Events and Healthcare Utilization: A nationwide assessment
VENTURE-AF: A Randomized Global Trial Evaluating Uninterrupted Rivaroxaban and Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Nonvalvular Atrial Fibrillation
Cryoballoon Versus Open Irrigated Radiofrequency Ablation in Patients with Paroxysmal Atrial Fibrillation: The prospective, randomized controlled, non-inferiority FreezeAF Study
Botulinum Toxin Injection in Epicardial Fat Pads for Prevention of Atrial Fibrillation After Cardiac Surgery: One year follow up of randomized pilot study
Wireless LV Endocardial Stimulation for CRT: Primary results of the Safety and Performance of Electrodes implanted in the Left Ventricle (SELECT-LV) Study
The Evera MRI Study
 
Session II: Friday, May 15, 2015, 8–9:30 a.m. EDT in Ballroom West?
Performance of a Miniaturized Transcatheter Pacing System: First-in-human experience
Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction: Safety and Efficacy in Patients with and without Chronic Resynchronization Therapy
Canadian Registry of Cardiac Implantable Electronic Device Outcomes: Phase 1 Riata Lead on Advisory (CREDO)
Clinical Safety of the Iforia ProMRI ICD System Subjected to 1.5T Cardiac or Thoracic Spine MRI
Effect of linear ablation in substrate-based AF: Results of the Substrate Modification with Ablation and Antiarrhythmic Drugs in Nonpermanent Atrial Fibrillation trial
Visually-Guided Laser Balloon (VGLB) Pulmonary Vein Isolation For The Treatment of Paroxysmal Atrial Fibrillation (PAF): Results Of The Prospective Multicenter Randomized Heartlight Study 
 
For more information: www.HRSonline.org
?
 

Related Content

News | EP Mapping and Imaging Systems

May 15, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...

Home May 15, 2023
Home
News | EP Mapping and Imaging Systems
April 29, 2022 – Vektor Medical has announced positive results from its “Vektor vMap Clinical Validation Study” ...
Home April 29, 2022
Home
News | EP Mapping and Imaging Systems

March 3, 2022 – CIRCA Scientific, Inc. has announced that its S-CATH M Esophageal Temperature Probe is now cleared for ...

Home March 03, 2022
Home
Videos | EP Mapping and Imaging Systems

An example of the Acutus Medical AcQMap High Resolution Imaging and Mapping System to guide electrophysiology (EP) ...

Home October 14, 2021
Home
News | EP Mapping and Imaging Systems

September 29, 2020 — The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the second-generation of ...

Home September 29, 2020
Home
News | EP Mapping and Imaging Systems

September 14, 2020 — Philips Healthcare released new imaging and workflow enhancements for its novel Kodex-EPD cardiac ...

Home September 14, 2020
Home
News | EP Mapping and Imaging Systems

August 17, 2020 — A Northwestern Medicine Bluhm Cardiovascular Institute physician was the first electrophyiologist in ...

Home August 17, 2020
Home
News | EP Mapping and Imaging Systems

October 15, 2019 — Kardium Inc. announced that the Globe mapping and ablation system has successfully demonstrated ...

Home October 15, 2019
Home
News | EP Mapping and Imaging Systems

October 9, 2019 — Acutus Medical and Innovative Health announced a partnership that will offer advanced ...

Home October 09, 2019
Home
News | EP Mapping and Imaging Systems

August 19, 2019 — Scientists at Johns Hopkins have successfully created personalized digital replicas of the upper ...

Home August 19, 2019
Home
Subscribe Now